A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas
Open Access
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (1) , 101-105
- https://doi.org/10.1038/bjc.1997.16
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary originEuropean Journal Of Cancer, 1993
- Management of peritoneal carcinomatosis of unknown primary tumor site.1993
- Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.Journal of Clinical Oncology, 1992
- Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.Journal of Clinical Oncology, 1991
- Management of squamous cell carcinoma of unknown origin in cervical lymph nodes.1986
- The Unrecognized Extragonadal Germ Cell Cancer SyndromeAnnals of Internal Medicine, 1981
- Reporting results of cancer treatmentCancer, 1981
- Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.BMJ, 1979
- Axillary Metastases from Unknown Primary SitesAnnals of Surgery, 1973
- Treatment of the patient with adenocarcinoma of unknown originCancer, 1972